$CV The share price has risen by over 100% recently, boosted by the third quarter results and news of the FDA approval application. Given the strong technical indicators, the rally could continue to +15 US dollars.
#stockanalysis
#etfs
#crypto
#tech
#dividends
#nasdaq
#nyse
#dax
#deutschland
#aktien
#aktie
$NOVO B (+2,42 %)
$ONDS (-4,71 %)
$BTC (-2,35 %)
$ETH (-1,36 %)